Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
4.670
+0.093 (2.03%)
Nov 7, 2025, 3:35 PM EST
Hypera Market Cap
Hypera has a market cap or net worth of $2.92 billion as of November 7, 2025. Its market cap has increased by 0.63% in one year.
Market Cap
2.92B
Enterprise Value
4.32B
Revenue
1.31B
Ranking
n/a
PE Ratio
18.88
Stock Price
$4.67
Market Cap Chart
Since April 18, 2008, Hypera's market cap has increased from 1.59B to 2.92B, an increase of 83.86%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.92B | 58.97% |
| Dec 30, 2024 | 1.84B | -60.72% |
| Dec 28, 2023 | 4.67B | -14.36% |
| Dec 29, 2022 | 5.46B | 70.31% |
| Dec 30, 2021 | 3.20B | -23.62% |
| Dec 30, 2020 | 4.20B | -25.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| CytoDyn | 330.81M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 305.39M |